查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032885

人工生命器官和醫用仿生學市場報告：按產品類型、應用和地區分類（2026-2034 年）

Artificial Vital Organs and Medical Bionics Market Report by Product Type (Artificial Vital Organs, Medical Bionics), Application (Hospitals, Clinics, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球人工器官和醫用仿生學市場規模達514億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到760億美元，2026年至2034年的複合年成長率為4.30%。呼吸系統疾病、肝硬化、心臟衰竭和肝功能衰竭的盛行率不斷上升，易受器官衰竭影響的老年人口不斷增加，以及各種技術的進步，都是推動市場成長的主要因素。

人工生命維持器官（也稱為假體器官或生物人工器官）是設計用於模擬人體天然器官功能的人工裝置。這些裝置旨在作為功能失調或喪失功能的生物器官的臨時或永久替代品，幫助患者維持，甚至在某些情況下改善維持生命的基本生理功能。另一方面，醫學仿生學是醫學和工程學的一個分支，專注於開發和整合生物和人工組件，以恢復或增強人體功能。

目前，包括呼吸系統疾病、肝硬化、心臟衰竭、腎衰竭和肝功能衰竭在內的多種疾病的發生率顯著上升。這一成長與醫療領域的不斷擴展密切相關，也是推動市場成長的關鍵因素。此外，全球老年人口的增加，尤其是易患器官相關疾病的老年人口，也大大促進了市場擴張。同時，全功能人工心臟、肝臟、肺臟、尿道、氣管和腎臟等創新產品的持續研發，也對市場動態產生了正面影響。此外，主要市場參與者正大力投資研發，以引進利用人工組織的尖端器官再生技術。這種持續創新為市場帶來了良好的前景。此外，能夠提高生存率並促進患者早期康復的生物人工器官的出現，也增加了對人工器官的需求。在嚴重病例中引入「移植橋接」和「康復橋接」等救生技術，進一步推動了這項需求的成長，鞏固了市場發展。

人工重要器官和醫用仿生學市場的趨勢和促進因素：

呼吸系統疾病、肝硬化和器官衰竭的發生率不斷上升。

慢性阻塞性肺病（COPD）和肺部感染疾病等呼吸系統疾病的發生率正在急劇上升。重症呼吸系統疾病患者通常需要人工肺部或其他輔助設備才能正常呼吸。此外，包括肝硬化在內的肝臟疾病也因多種因素而日益增多，例如過度飲酒、病毒性肝炎和非酒精性脂肪性肝病。在肝硬化晚期，患者可能需要進行肝臟移植，而人工肝臟可以作為移植前的過渡性治療或長期解決方案。心臟衰竭和肝功能衰竭也是全球嚴重的健康問題。由於老化、肥胖和不良生活方式等因素，鬱血性和末期肝病等疾病的發生率正在上升。人工心臟和肝臟支持系統在提供挽救生命的解決方案方面發揮著至關重要的作用，無論是作為患者等待移植期間的臨時或永久性支持。

全球老化進程

世界人口結構正朝著老化方向發展。由於老年人更容易因自然老齡化過程而出現器官衰竭，因此他們是人工生命維持器官治療的主要目標族群。此外，老年人也更容易罹患心血管疾病、呼吸系統疾病和腎臟疾病等慢性疾病。這些疾病通常需要人工心臟、肺部和腎臟等治療性介入來維持和改善患者的生活品質。心臟心律調節器和人工電子耳醫療器材也常用於老年人，以解決與老齡化相關的健康問題。人工維生器官和仿生醫療器材對於延長老年人的壽命和提高他們的生活品質至關重要，使他們能夠在晚年享受更高品質的生活。

各種技術進步

醫療技術的進步顯著提升了人工生命維持器官和醫用仿生技術的設計、功能和有效性。此外，功能齊全的人工器官，例如人工心臟和人工肺，憑藉其更先進的特性，使患者能夠擁有更積極的生活。同時，尖端材料與生物工程技術的融合，催生了能夠高度模擬天然器官的生物人工器官，降低了排斥反應的風險，並改善了患者的整體預後。此外，醫療科技產業的領導者正大力投資於旨在改善人工器官和醫用仿生技術的研發活動。這些投資正推動更先進的醫療設備、更優質的材料和更先進的外科手術技術的研發，所有這些都有助於改善病患的治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：人工生命器官與醫用仿生學的全球市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 人工器官
    • 主要部分
      • 人工肝臟
      • 人工心臟
      • 人工胰臟
      • 人工腎臟
      • 人工肺
      • 氧合裝置
  • 醫用仿生學
    • 主要部分
      • 仿生義肢
      • 視覺仿生學
      • 耳朵仿生學
      • 外骨骼
      • 腦仿生學
      • 心臟瓣膜
      • 心臟仿生學

第7章 市場區隔：依應用領域分類

  • 醫院
  • 診所
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abiomed
    • BiVACOR Inc
    • CARMAT
    • Cirtec Medical
    • Edwards Lifesciences
    • Ekso Bionics Holdings Inc.
    • Nikkiso Co. Ltd.
    • Second Sight Medical Products Inc
    • SynCardia Systems LLC（Picard Medical Inc.）
Product Code: SR112026A6458

The global artificial vital organs and medical bionics market size reached USD 51.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 76.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.30% during 2026-2034. The rising prevalence of respiratory ailments, cirrhosis, and heart and liver failures, the increasing geriatric population that is highly prone to organ disorders, and various technological advancements represent some of the key factors driving the market.

Artificial vital organs, often referred to as artificial organs or bioartificial organs, are man-made devices designed to mimic the functions of natural organs within the human body. These devices are developed to serve as temporary or permanent replacements for malfunctioning or failed biological organs, helping patients maintain essential bodily functions and, in some cases, even enhancing them. On the other hand, medical bionics is a field of medical science and engineering that focuses on the development and integration of biological and artificial components to restore or enhance the functioning of the human body.

Currently, there is a notable surge in the prevalence of various medical conditions, including respiratory disorders, cirrhosis, as well as heart, kidney, and liver failures. This surge is closely tied to the expanding healthcare sector and serves as a significant catalyst for market growth. Furthermore, the increasing elderly population, which is particularly susceptible to organ-related ailments worldwide, is making a substantial contribution to the market's expansion. Moreover, the continuous development of innovative products, such as fully functional artificial hearts, livers, lungs, urethras, windpipes, and kidneys, is exerting a positive impact on market dynamics. Additionally, major market players are making substantial investments in research and development (R&D) endeavors, aimed at introducing cutting-edge methods of organ regeneration through engineered tissues. This ongoing innovation is fostering a promising outlook for the market. Besides this, there is a rising demand for artificial organs, driven by the emergence of bioartificial organs that offer improved survival rates and faster patient recovery. This growing demand is further propelled by the implementation of life-saving technologies like the bridge to transplant and the bridge to recovery in critical medical cases, further reinforcing market growth.

ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET TRENDS/DRIVERS:

Rising prevalence of respiratory ailments, cirrhosis, and organ failures

There has been a notable increase in the prevalence of respiratory ailments such as chronic obstructive pulmonary disease (COPD) and lung infections. Patients with severe respiratory issues often require artificial lungs or other assistive devices to breathe adequately. Moreover, liver diseases, including cirrhosis, have seen a rise due to various factors like excessive alcohol consumption, viral hepatitis infections, and non-alcoholic fatty liver disease. In advanced stages, cirrhosis may necessitate liver transplantation, and artificial livers can serve as a bridge to transplantation or even a long-term solution. Besides, heart and liver failures are significant health concerns worldwide. Conditions like congestive heart failure and end-stage liver disease are on the rise due to factors such as an aging population, obesity, and lifestyle choices. Artificial hearts and liver support systems play a crucial role in providing life-saving solutions while patients await transplantation or as a permanent support option.

Increasing geriatric population across the globe

The global demographic landscape is shifting toward an aging population. Elderly individuals are more susceptible to organ disorders due to the natural aging process, making them a key demographic for artificial vital organ interventions. Besides, the elderly population is more prone to chronic medical conditions, including cardiovascular diseases, respiratory ailments, and kidney disorders. These conditions frequently require interventions such as artificial hearts, lungs, or kidneys to manage or improve the patient's quality of life. Medical bionics, such as pacemakers and cochlear implants, are also commonly used in elderly individuals to address age-related health issues. Artificial vital organs and medical bionics become crucial in extending and improving the lives of these elderly individuals, allowing them to enjoy a better quality of life in their later years.

Various technological advancements

Advancements in medical technology have significantly improved the design, functionality, and effectiveness of artificial vital organs and medical bionics. Moreover, full-functioning artificial organs, such as artificial hearts and lungs, have been developed with enhanced capabilities, allowing patients to lead more active lives. Besides, the integration of cutting-edge materials and bioengineering techniques has led to the creation of bioartificial organs that closely mimic natural organs, reducing the risk of rejection and improving overall patient outcomes. Additionally, leading players in the medical technology industry are investing heavily in research and development activities aimed at improving artificial vital organs and medical bionics. These investments result in the development of more sophisticated devices, enhanced materials, and improved surgical techniques, all of which contribute to better patient outcomes.

KEY MARKET SEGMENTATION:

Breakup by Product Type:

  • Artificial Vital Organs
    • Artificial Liver
    • Artificial Heart
    • Artificial Pancreas
    • Artificial Kidney
    • Artificial Lungs
    • Oxygenators
  • Medical Bionics
    • Bionic Limbs
    • Vision Bionics
    • Ear Bionics
    • Exoskeletons
    • Brain Bionics
    • Heart Valves
    • Cardiac Bionics

Artificial vital organs represent the most used product type

Artificial vital organs are designed to mimic the functions of natural vital organs such as the heart, lungs, kidneys, and liver. These devices are often used as a last resort when a patient's natural organs fail. They serve a life-saving function, providing crucial support to sustain a patient's life until a transplant becomes available or the natural organs recover. Moreover, there is a consistently high demand for artificial vital organs due of the prevalence of organ failure and the limited availability of organ donors. Individuals worldwide suffer from conditions that can lead to organ failure, and the demand for replacement organs far exceeds the supply. Artificial vital organs bridge this gap by offering a viable solution to patients in critical need.

Breakup by Application:

  • Hospitals
  • Clinics
  • Others

Hospitals are a primary application for artificial vital organs and medical bionics. In these healthcare facilities, artificial vital organs such as artificial hearts, lungs, and kidneys are often used to support patients with organ failure while they await transplants. Additionally, medical bionics, including devices like cochlear implants and bionic limbs, may be provided to patients in hospital settings to improve their quality of life and functional capabilities.

Clinics, including specialized medical centers and outpatient facilities, play a crucial role in the application of artificial vital organs and medical bionics. These settings are where patients may receive diagnosis, consultation, and follow-up care related to these advanced medical technologies. Clinics often offer services related to the assessment, fitting, and maintenance of medical bionics, making them essential in the continuum of care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America, particularly the United States and Canada, boasts a highly advanced healthcare infrastructure with state-of-the-art medical facilities and research institutions. This infrastructure fosters innovation and the development of cutting-edge medical technologies, including artificial vital organs and medical bionics. Besides, the region is a global hub for medical research and development. Leading universities, medical centers, and private companies collaborate to push the boundaries of medical science. This collaborative environment accelerates the creation and commercialization of medical bionics and artificial vital organs. Moreover, the region has well-established regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and Health Canada, which ensure the safety and efficacy of medical devices. A robust regulatory framework provides confidence to investors, manufacturers, and healthcare providers, encouraging the development and adoption of medical bionics.

COMPETITIVE LANDSCAPE:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are heavily investing in R&D to develop innovative and advanced artificial vital organs and medical bionics. They focus on improving the performance, durability, and safety of these devices, as well as reducing their size and enhancing compatibility with the human body. They are also expanding their product portfolios to cover a broader range of medical bionics and artificial organs. This diversification allows them to address a wider array of medical conditions and patient needs. Besides, companies are acquiring or merging with other companies in the industry to expand capabilities, gain access to new technologies, and increase market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abiomed
  • BiVACOR Inc
  • CARMAT
  • Cirtec Medical
  • Edwards Lifesciences
  • Ekso Bionics Holdings Inc.
  • Nikkiso Co. Ltd.
  • Second Sight Medical Products Inc
  • SynCardia Systems LLC (Picard Medical Inc.)

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Vital Organs and Medical Bionics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Artificial Vital Organs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Artificial Liver
      • 6.1.2.2 Artificial Heart
      • 6.1.2.3 Artificial Pancreas
      • 6.1.2.4 Artificial Kidney
      • 6.1.2.5 Artificial Lungs
      • 6.1.2.6 Oxygenators
    • 6.1.3 Market Forecast
  • 6.2 Medical Bionics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bionic Limbs
      • 6.2.2.2 Vision Bionics
      • 6.2.2.3 Ear Bionics
      • 6.2.2.4 Exoskeletons
      • 6.2.2.5 Brain Bionics
      • 6.2.2.6 Heart Valves
      • 6.2.2.7 Cardiac Bionics
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abiomed
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BiVACOR Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 CARMAT
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cirtec Medical
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Ekso Bionics Holdings Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Nikkiso Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Second Sight Medical Products Inc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 SynCardia Systems LLC (Picard Medical Inc.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Vital Organs and Medical Bionics Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: North America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: North America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: United States: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: United States: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Canada: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Canada: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: China: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: China: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Japan: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Japan: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: India: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: India: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: South Korea: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: South Korea: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Australia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Australia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Indonesia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Indonesia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Europe: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Europe: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Germany: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Germany: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: France: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: France: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: United Kingdom: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: United Kingdom: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Italy: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Italy: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Spain: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Spain: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Russia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Russia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Latin America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Latin America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Brazil: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Brazil: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Mexico: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Mexico: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Breakup by Country (in %), 2025
  • Figure 65: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Global: Artificial Vital Organs and Medical Bionics Industry: SWOT Analysis
  • Figure 67: Global: Artificial Vital Organs and Medical Bionics Industry: Value Chain Analysis
  • Figure 68: Global: Artificial Vital Organs and Medical Bionics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Vital Organs and Medical Bionics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Artificial Vital Organs and Medical Bionics Market: Competitive Structure
  • Table 6: Global: Artificial Vital Organs and Medical Bionics Market: Key Players